|Special issue entitled: "Management of Peripheral Arterial Disease" has been edited by|
Dr. Smriti. M. Krishna
Impact Factor: 1.77*
Cardiovascular Pharmacology Journal has the increasing role in diagnosis, characterization, therapy of various marked diseases in the field of Medical Science. The journal aims to promote international dialogue and collaboration on health issues to improve clinical practice and to expand and deepen the understanding of health and health care.
The journal includes a wide range of fields which mainly deals with Angina, Stroke & all Heart diseases and its pharmacology related to all living organisms.
Cardiovascular Pharmacology is an Open Access journal that aims to publish the most complete and reliable source of information on the discoveries and current developments as original articles, review articles, case reports, short communications, etc. in all areas of the field and make them available online to the researchers worldwide without any subscriptions.
The Journal provides a unique forum dedicated to scientists to express their research on a wide array of Cardiovascular Pharmacology topics. The Cardiovascular Pharmacology Peer Reviewed Journal is proficiently supported by universally prominent Editorial Board members. Cardiovascular Pharmacology journal impact factor is mainly calculated based on the number of articles published and cited on a given year.
OMICS International organizes 1000 conferences every year across USA, Europe & Asia with support from 1000 more scientific societies, 400+symposiums and Publishes 700 Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Cardiovascular Pharmacology mainly contributes to the safety profile of potential new drugs and provide pharmacological data that can be used for optimization of further compounds and the ultimate selection of compounds suitable for clinical development.
Cardiovascular Toxicology deals with the adverse effects on the heart or blood systems which result from exposure to toxic chemicals. It describes safety data of detrimental effects of new cardiovascular drugs.
Cardiovascular Pharmacotherapy is a fast-moving and complex discipline within Cardiology. The timing of therapy to match biological need through chronotherapeutics, with attention to chronobiology.
Cardiovascular Drugs Market Analysis provides cardiovascular drugs market analysis, key products, and competitive landscape in India. This research helps executives understand the cardiovascular drugs market landscape in India.
Electrocardiography is the process of recording the electrical activity of the heart over a period of time using electrodes placed on a patient's body.
Cardiovascular physiology is the study of the circulatory system, specifically addressing the physiology of the heart and blood vessels.
Cardiac catheterization is a procedure used to diagnose and treat cardiovascular conditions. During cardiac catheterization, a long thin tube called a catheter is inserted in an artery or vein in your groin, neck or arm and threaded through your blood vessels to your heart.
Myocardial Infraction refers to damage or death of an area of the heart muscle (myocardium) resulting from a blocked blood supply to the area. The affected tissue dies, injuring the heart. Symptoms include prolonged, intensive chest pain and a decrease in blood pressure that often causes shock
Cardiomyopathy is the measurable deterioration for any reason of the ability of the myocardium (the heart muscle) to contract, usually leading to heart failure. It is usually a sign of an underlying problem, such as high blood pressure, heart valve problems.
The technique of using moving pictures to show how a special dye passes through blood vessels, allowing doctors to diagnose diseases of the heart and blood vessels.
A disease of the heart (mainly affecting the heart valves) caused by Rheumatic fever.
Also called coronary artery disease and coronary heart disease, this term is applied to heart problems caused by narrowing of the coronary arteries, thereby causing a decreased blood supply to the heart.
Refers to conditions affecting the heart and blood vessels. It include coronary artery disease, valve disease, arrhythmia, Peripheral vascular disease, Congenital heart defects, Hypertension, and Cardiomyopathy.
Cardiac dysrhythmias is a group of conditions in which the heartbeat is irregular, too fast, or too slow.
An emergency measure that can maintain a person's breathing and heartbeat. The person who performs CPR actually helps the patient's circulatory system by breathing into the patient's mouth to give them oxygen and by giving chest compressions to circulate the patient's blood
Congestive Heart Failure is a condition in which the heart cannot pump all the blood returning to it, leading to a backup of blood in the vessels and an accumulation of fluid in the body's tissues, including the lungs.
Disease of the heart caused by a buildup of atherosclerotic plaque in the coronary arteries that can lead to Angina pectoris or Heart attack.
A term for the muscle and weight loss caused by severe heart disease. It is often related to the depressed cardiac output associated with end-stage Heart failure, but it can also occur with severe coronary artery disease.
Cardiac Arrest refers to stopping of the heartbeat, usually because of interference with the electrical signal.
Cyanotic Heart Disease is a birth defect of the heart that causes oxygen-poor (blue) blood to circulate to the body without first passing through the lungs.
OMICS International is honoured to invite all the participants to join conference International Conference and Exhibition on Pediatric Cardiology during August 25-27, 2015 at Valencia, Spain with the innovative theme “Challenges in pediatric and congenital cardiac disease”. This conference mainly focuses on spreading the awareness about challenges in this field and how to prevent the cardiac diseases. We are awaiting a great scientific faculty from Europe as well as other continents and expect a highly interesting scientific as well as a representative event.
*Unofficial 2014 Impact Factor was established by dividing the number of articles published in 2012 and 2013 with the number of times they are cited in 2014 based on Google search and the Scholar Citation Index database. If ‘X’ is the total number of articles published in 2012 and 2013, and ‘Y’ is the number of times these articles were cited in indexed journals during 2014 than, impact factor = X/Y